Brand-Ad-30-6
 IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 2842 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
Read this article

 


    Article Cited by others

FOCUS

Use of fumaric acid esters in psoriasis

Roll Antonie, Reich Kristian, Boer Almut

Year : 2007| Volume: 73| Issue : 2 | Page no: 133-137

   This article has been cited by
 
1 DMF, but not other fumarates, inhibits NF-?B activity in vitro in an Nrf2-independent manner
Geoffrey O. Gillard,Brian Collette,John Anderson,Jianhua Chao,Robert H. Scannevin,David J. Huss,Jason D. Fontenot
Journal of Neuroimmunology. 2015; 283: 74
[Pubmed]  [Google Scholar] [DOI]
2 Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy
Simon A. Broadley,Michael H. Barnett,Mike Boggild,Bruce J. Brew,Helmut Butzkueven,Robert Heard,Suzanne Hodgkinson,Allan G. Kermode,Jeannette Lechner-Scott,Richard A.L. Macdonell,Mark Marriott,Deborah F. Mason,John Parratt,Stephen W. Reddel,Cameron P. Shaw,Mark Slee,Judith Spies,Bruce V. Taylor,William M. Carroll,Trevor J. Kilpatrick,John King,Pamela A. McCombe,John D. Pollard,Ernest Willoughby
Journal of Clinical Neuroscience. 2014;
[Pubmed]  [Google Scholar] [DOI]
3 Fumaric acid and its esters: An emerging treatment for multiple sclerosis with antioxidative mechanism of action
R. Gold, R.A. Linker, M. Stangel
Clinical Immunology. 2011;
[HTML Full text]  [Google Scholar] [DOI]
4 Emerging oral therapies for multiple sclerosis
Miller, C.E., Umhauer, M.A.
Journal of Neuroscience Nursing. 2011; 43(1): 3-14
[Pubmed]  [Google Scholar]
5 Therapy of MS
Vosoughi, R., Freedman, M.S.
Clinical Neurology and Neurosurgery. 2010; 112(5): 365-385
[Pubmed]  [Google Scholar]
6 BG-12: NF-κB activation inhibitor treatment of multiple sclerosis
Moharregh-Khiabani, D., Stangel, M.
Drugs of the Future. 2010; 35(2): 93-97
[Pubmed]  [Google Scholar]
7 Therapy of MS
Reza Vosoughi,Mark S. Freedman
Clinical Neurology and Neurosurgery. 2010; 112(5): 365
[Pubmed]  [Google Scholar] [DOI]
8 Fumaric acid and its derivatives in the treatment of psoriasis vulgaris: Our experience in forty-one patients
Kokelj, F., Plozzer, C., Avian, A., Trevisan, G.
Acta Dermatovenerologica Croatica. 2009; 17(3): 170-175
[Pubmed]  [Google Scholar]
9 Fumaric acid and its esters: An emerging treatment for multiple sclerosis
Moharregh-Khiabani, D., Linker, R.A., Gold, R., Stangel, M.
Current Neuropharmacology. 2009; 7(1): 60-64
[Pubmed]  [Google Scholar]
10 Opportunistic infections and other risks with newer multiple sclerosis therapies
Berger, J.R., Houff, S.
Annals of Neurology. 2009; 65(4): 367-377
[Pubmed]  [Google Scholar]
11 Opportunistic infections and other risks with newer multiple sclerosis therapies
Joseph R. Berger,Sidney Houff
Annals of Neurology. 2009; 65(4): 367
[Pubmed]  [Google Scholar] [DOI]

 

Online since 15th March '04
Published by Wolters Kluwer - Medknow